In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Coordinating Research and Evidence for Medical Devices (CORE-MD)

CORE-MD is a Horizon 2020 project which will start on 1 April 2021. Its mission is "Translating expert knowledge into advice for EU regulatory guidance, and building expertise in regulatory science in the clinical community".

Core-MD-Acronym+Name RGB.jpg

Breakdown of the Initiative

CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. 

The project will be achieved through a unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies. 

The consortium is led by the European Society of Cardiology, in close partnership with the European Federation of National Associations of Orthopaedics and Traumatology and involves all 35 specialist medical associations that are members of the Biomedical Alliance in Europe. Final recommendations will be submitted to the European Commission's Working Group on Clinical Investigation and Evaluation for consideration when developing EU guidance or common specifications.


Kick-Off Meeting Press Release

Work Packages 

The CORE-MD Project consists of five Work Packages. 

Work Package 1 aims at understanding the methods that have been used to generate clinical evidence for high-risk medical devices. 

Work Package 2 aims at strengthening the clinical evidence for high-risk medical devices by exploring new methods for generating data about their performance. 

The main objective of Work Package 3 is to extract maximal value from medical device registries and real-world evidence.

 Work Package 4 and Work Package 5 will focus respectively on engagement with stakeholders, and project management.

Work Flow Chart.jpg







Partners in the CORE-MD Consortium

Société Eurpéenne de Cardiologie / European Society of Cardiology

European Federation of the National Associations of Orthopaedics and Traumatology (EFORT)

Biomedical Alliance

European Academy of Paediatrics

European Patients Forum

Academisch Ziekenhuis Leiden (Leiden University Medical Center)

The Chancellor, Masters and Scholars of the University of Oxford

Region Uppsala

Royal College of Surgeons in Ireland 

Insel Gruppe Ag (University Hospital Bern) 

Katholieke Universiteit Leuven

UMIT - Private Universität für Gesundheitswissenschaften, Medizinischeinformatik und Technik GmbH (University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria)

Göteborgs Universitet (Gothenburg University) 

Politecnico di Milano (Polytechnic University of Milan)

Health Products Regulatory Authority (Dublin) 

Laegemiddelstyrelsen (Danish Medicines Agency, Copenhagen)

Urzad Rejestracji Produktow Leczniczych, Wyrobow Medzycznych i Produktow Biobojczych (Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Warsaw)

Rijksinstituut Voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment, Bilthoven, the Netherlands) 

Istituto Superiore di Sanita (Italian National Institute of Health, Rome) 

HTA Austria - Austrian Institute for Health Technology Assessment GmbH (Vienna)

Fundacion Publica Andaluza Progreso y Salud (Progress and Health Foundation, Sevilla) 

European Association of Notified Bodies for Medical Devices


Prof. Alan Fraser

CORE-MD Scientific Coordinator 

European Society of Cardiology 

Brussels, Belgium

Project Website

The website of the project ( is under preparation. 

Funding Acknowledgement

EU Flag.pngThe project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 965246